Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renova Nutrition is a specialized healthcare company that develops and markets clinically-supported probiotic and prebiotic supplements, with a primary focus on renal health. As the consumer-facing division of Kibow Biotech, the company utilizes the concept of "Enteric Dialysis" to help manage the buildup of uremic toxins in patients with compromised kidney function. Its flagship product, Renadyl, is a patented probiotic formulation designed to metabolize nitrogenous waste products like urea and creatinine within the colon. Beyond nephrology, Renova Nutrition offers a range of supplements targeting general digestive health and immune system support. The company's products are backed by over two decades of research and multiple clinical studies aimed at improving the quality of life for individuals with chronic kidney disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renova Nutrition.